Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression

Go back to Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression

Marinus Pharmaceuticals (MRNS) PT Raised to $22 at Ladenburg Thalmann

December 11, 2018 7:06 AM EST

Ladenburg Thalmann analyst Michael Higgins raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $22.00 (from $20.00) while maintaining a Buy rating.

... More